EIF2A and hepatocellular carcinoma: Experiments designed to completely disrupt SGs, without affecting the phosphorylating of eIF2α, the upstream inducer of ATF4, are required to validate the role of SGs in regulating the expression of ATF4 mRNA in HCC.